|Articles|August 14, 2008 (Updated: November 14, 2020)
Drug Designed to Fight MS Could Target Viral Infections
Advertisement
Reuters is reporting today that a new drug, FTY720, also called fingolimod, that Novartis AG is testing in individuals with multiple sclerosis could also tackle some viral infections, including perhaps including meningitis and perhaps even the AIDS virus. For the complete article,
Source: Reuters
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Why Antifungal Drug Development Remains So Challenging According to John Rex, MD
2
Inside Disinfectant R&D: What Infection Preventionists Need to Know About Efficacy, Safety, and Real-World Performance
3
Beyond Viral Suppression: Next-Generation HIV Therapeutics Target Reservoirs, Broadly Neutralizing Antibodies, and Gene Editing
4
Hospital-Onset Bacteremia in Burn Patients May Be a Poor Quality Metric, Study Finds
5